Congenital kaposiform hemangioendothelioma with kasabach-merritt phenomenon successfully treated with low-dose radiation therapy

Yogangi Malhotra; Catherine S. Yang; Joseph McNamara; Richard J. Antaya

doi:10.1111/pde.12090

Congenital kaposiform hemangioendothelioma with kasabach-merritt phenomenon successfully treated with low-dose radiation therapy

Yogangi Malhotra, Catherine S. Yang, Joseph McNamara, Richard J. Antaya

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.

Original language	English (US)
Pages (from-to)	595-598
Number of pages	4
Journal	Pediatric Dermatology
Volume	31
Issue number	5
DOIs	https://doi.org/10.1111/pde.12090
State	Published - 2014
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Dermatology

Access to Document

10.1111/pde.12090

Cite this

@article{e23f04c243074e6e950fb53a9d8a859f,

title = "Congenital kaposiform hemangioendothelioma with kasabach-merritt phenomenon successfully treated with low-dose radiation therapy",

abstract = "Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.",

author = "Yogangi Malhotra and Yang, {Catherine S.} and Joseph McNamara and Antaya, {Richard J.}",

note = "Publisher Copyright: {\textcopyright} 2013 Wiley Periodicals, Inc.",

year = "2014",

doi = "10.1111/pde.12090",

language = "English (US)",

volume = "31",

pages = "595--598",

journal = "Pediatric Dermatology",

issn = "0736-8046",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Congenital kaposiform hemangioendothelioma with kasabach-merritt phenomenon successfully treated with low-dose radiation therapy

AU - Malhotra, Yogangi

AU - Yang, Catherine S.

AU - McNamara, Joseph

AU - Antaya, Richard J.

PY - 2014

Y1 - 2014

N2 - Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.

AB - Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.

UR - http://www.scopus.com/inward/record.url?scp=84908380416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908380416&partnerID=8YFLogxK

U2 - 10.1111/pde.12090

DO - 10.1111/pde.12090

M3 - Article

C2 - 23458157

AN - SCOPUS:84908380416

SN - 0736-8046

VL - 31

SP - 595

EP - 598

JO - Pediatric Dermatology

JF - Pediatric Dermatology

IS - 5

ER -

Congenital kaposiform hemangioendothelioma with kasabach-merritt phenomenon successfully treated with low-dose radiation therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this